Form 4: Heartflow Director Acquires Stock Options

Heartflow, Inc. director Casey M. Tansey acquired 16,075 stock options with an exercise price of $32.05.

Summary

• Casey M. Tansey, a Director at Heartflow, Inc., acquired 16,075 stock options on June 16, 2026.
• The options have an exercise price of $32.05.
• These options are set to vest in full on the day prior to Heartflow's annual shareholder meeting in 2027 or the first anniversary of the grant date, whichever comes first, provided service continues.
• The filing indicates this transaction was made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director under a pre-existing plan, with no immediate financial impact or significant strategic revelation.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The transaction was made under a Rule 10b5-1(c) plan, suggesting a pre-planned and potentially less market-impacting transaction.

Risks

• The vesting schedule for the options is contingent on continued service, meaning the director could forfeit them if they leave the company before the vesting date.
• The exercise price of $32.05 implies that the stock price needs to increase significantly for the options to be profitable.

Future Outlook

The stock options are exercisable at $32.05 and will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that insider option grants, especially to directors, are common in the healthcare technology sector as a means of aligning executive interests with shareholder value and incentivizing long-term performance.

Stakeholder Impact

• Shareholders: The grant of options does not immediately dilute share count but represents potential future dilution if exercised. It can also be seen as a positive signal of director commitment.
• Employees: Indirectly, such grants can contribute to a culture of long-term incentive alignment.
• Management: Reinforces the alignment of director compensation with company performance.

Next Steps

• The stock options will vest according to the schedule outlined, contingent on continued service.
• The director may choose to exercise the options if the stock price exceeds the exercise price of $32.05 after vesting.

Key Dates

Keywords

Heartflow Inc, HTFL, Form 4, Stock Options, Insider Trading, Director, SEC Filing, Beneficial Ownership